These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6381011)

  • 1. Allergies to human insulin.
    Berke L; Owen JA; Atkinson RL
    Diabetes Care; 1984; 7(4):402-3. PubMed ID: 6381011
    [No Abstract]   [Full Text] [Related]  

  • 2. Desensitization-resistant insulin allergy.
    Frigerio C; Aubry M; Gomez F; Graf L; Dayer E; de Kalbermatten N; Gaillard RC; Spertini F
    Allergy; 1997 Feb; 52(2):238-9. PubMed ID: 9105538
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic tolerance to the insulin analogue glulisine.
    Ozaki N; Oiso Y
    Diabetes Care; 2010 Mar; 33(3):e39. PubMed ID: 20190287
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic tolerance to intravenously injected insulin.
    Asai M; Yoshida M; Miura Y
    N Engl J Med; 2006 Jan; 354(3):307-9. PubMed ID: 16421379
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune reactions caused by insulin].
    Velcovsky HG
    Fortschr Med; 1986 Jun; 104(21):431-4. PubMed ID: 3525358
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperpigmentation due to insulin allergy.
    Neki NS; Gupta SN; Mani T; Gupta H
    Natl Med J India; 2014; 27(3):183. PubMed ID: 25668097
    [No Abstract]   [Full Text] [Related]  

  • 7. Omalizumab for drug allergy.
    Matheu V; Franco A; Perez E; Hernández M; Barrios Y
    J Allergy Clin Immunol; 2007 Dec; 120(6):1471-2; author reply 1472-3. PubMed ID: 17854881
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes.
    Moriyama H; Nagata M; Fujihira K; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Ueda H; Yokono K
    Diabetes Care; 2001 Feb; 24(2):411-2. PubMed ID: 11213905
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged desensitization required for treatment of generalized allergy to human insulin.
    Thompson DM; Ronco JJ
    Diabetes Care; 1993 Jun; 16(6):957-8. PubMed ID: 8325221
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary allergy to human insulin in patient with gestational diabetes.
    Balsells MC; Corcoy RM; Lleonart RB; Pujol RV; Mauricio DP; García AP; Pou JM; Cisteró AB
    Diabetes Care; 1991 May; 14(5):423-4. PubMed ID: 2060455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of allergy to monocomponent porcine and bovine insulin with monocomponent human insulin].
    Bruni B; Campana M; Carlini M; Gamba Ansaldi S; Grassi G; Regis G; Turco GL
    Minerva Endocrinol; 1984; 9(2):173-9. PubMed ID: 6390132
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
    Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
    Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of monocomponent insulin & effect on insulin binding capacity.
    Shivgnanasundaram D; Ahuja MM; Godble MM
    Indian J Med Res; 1984 May; 79():652-6. PubMed ID: 6392084
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
    Eapen SS; Connor EL; Gern JE
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):395-7. PubMed ID: 11101184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme insulin resistance: a consequence of insulin switching?
    Keenan WF; Abgott MA
    J Fam Pract; 1988 Dec; 27(6):635-6. PubMed ID: 3058859
    [No Abstract]   [Full Text] [Related]  

  • 18. [Insulin allergies].
    Sola-Gazagnes A
    Soins; 2007 Apr; (714 Suppl):S2, S4-5. PubMed ID: 17569273
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
    Lassmann-Vague V; SanMarco M; LeJeune PJ; Alessis C; Vague P; Belicar P
    Diabetes Care; 1998 Nov; 21(11):2041-4. PubMed ID: 9802775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.